BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 31545802)

  • 1. Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach.
    Guirro M; Costa A; Gual-Grau A; Herrero P; Torrell H; Canela N; Arola L
    PLoS One; 2019; 14(9):e0218143. PubMed ID: 31545802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity.
    Sen T; Cawthon CR; Ihde BT; Hajnal A; DiLorenzo PM; de La Serre CB; Czaja K
    Physiol Behav; 2017 May; 173():305-317. PubMed ID: 28249783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice.
    Le Bastard Q; Ward T; Sidiropoulos D; Hillmann BM; Chun CL; Sadowsky MJ; Knights D; Montassier E
    Sci Rep; 2018 Apr; 8(1):6219. PubMed ID: 29670191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
    Tang TWH; Chen HC; Chen CY; Yen CYT; Lin CJ; Prajnamitra RP; Chen LL; Ruan SC; Lin JH; Lin PJ; Lu HH; Kuo CW; Chang CM; Hall AD; Vivas EI; Shui JW; Chen P; Hacker TA; Rey FE; Kamp TJ; Hsieh PCH
    Circulation; 2019 Jan; 139(5):647-659. PubMed ID: 30586712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of different hypercaloric diets on obesity features in rats: a metagenomics and metabolomics integrative approach.
    Gual-Grau A; Guirro M; Mayneris-Perxachs J; Arola L; Boqué N
    J Nutr Biochem; 2019 Sep; 71():122-131. PubMed ID: 31336215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics approach to elucidate the gut microbiota activity: Metaproteomics and metagenomics connection.
    Guirro M; Costa A; Gual-Grau A; Mayneris-Perxachs J; Torrell H; Herrero P; Canela N; Arola L
    Electrophoresis; 2018 Jul; 39(13):1692-1701. PubMed ID: 29427518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary pomegranate extract and inulin affect gut microbiome differentially in mice fed an obesogenic diet.
    Zhang S; Yang J; Henning SM; Lee R; Hsu M; Grojean E; Pisegna R; Ly A; Heber D; Li Z
    Anaerobe; 2017 Dec; 48():184-193. PubMed ID: 28870713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new animal diet based on human Western diet is a robust diet-induced obesity model: comparison to high-fat and cafeteria diets in term of metabolic and gut microbiota disruption.
    Bortolin RC; Vargas AR; Gasparotto J; Chaves PR; Schnorr CE; Martinello KB; Silveira AK; Rabelo TK; Gelain DP; Moreira JCF
    Int J Obes (Lond); 2018 Mar; 42(3):525-534. PubMed ID: 28895587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiota-gut-brain axis in obesity.
    Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect.
    Beckmann L; Künstner A; Freschi ML; Huber G; Stölting I; Ibrahim SM; Hirose M; Freitag M; Langan EA; Matschl U; Galuska CE; Fuchs B; Knobloch JK; Busch H; Raasch W
    Pharmacol Res; 2021 Aug; 170():105724. PubMed ID: 34116209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Short-Term Dietary Intervention and Probiotic Mix Supplementation on the Gut Microbiota of Elderly Obese Women.
    Cancello R; Turroni S; Rampelli S; Cattaldo S; Candela M; Cattani L; Mai S; Vietti R; Scacchi M; Brigidi P; Invitti C
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet.
    Mahana D; Trent CM; Kurtz ZD; Bokulich NA; Battaglia T; Chung J; Müller CL; Li H; Bonneau RA; Blaser MJ
    Genome Med; 2016 Apr; 8(1):48. PubMed ID: 27124954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis.
    Liao X; Song L; Zeng B; Liu B; Qiu Y; Qu H; Zheng Y; Long M; Zhou H; Wang Y; Du Y; Xu J; Shen R; Tong Q; Cai L; Li X; Guo S; Yang G; Zhu Z; Pu X; Wei H; Zheng H
    EBioMedicine; 2019 Jun; 44():665-674. PubMed ID: 30922964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.